Revenue Memorandum Circular No.62-2020

Revenue Memorandum Circular No. 62-2020

Publishing the full text of the letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) containing the “List of Prescription Drugs and Medicine for Diabetes, High-Cholesterol and Hypertension Exempt from VAT beginning January 27, 2020” pursuant to Section 1 Republic Act No. 11467